30026311000001100: Almotriptan 12.5mg tablets (DE Pharmaceuticals) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Almotriptan 12.5mg tablets (DE Pharmaceuticals)
\UK product\Virtual medicinal product\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)
\UK product\Virtual therapeutic moiety\Almotriptan\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)

\Medicinal product\Medicinal product categorized by disposition\Product containing serotonin receptor agonist (product)\Product containing serotonin 5-hydroxytryptamine-1 receptor agonist\Product containing almotriptan\Almotriptan\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing almotriptan\Almotriptan\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing sulfonamide\Product containing almotriptan\Almotriptan\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide\Product containing almotriptan\Almotriptan\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antimigraine agent (product)\Product containing almotriptan\Almotriptan\Almotriptan 12.5mg tablets\Almotriptan 12.5mg tablets (DE Pharmaceuticals)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93689101000001115 Almotriptan 12.5mg tablets (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93689201000001110 Almotriptan 12.5mg tablets (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Is a	Almotriptan 12.5mg tablets	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Is a	Almotriptan 12.5mg tablets	false	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Is a	Product containing precisely almotriptan malate 12.5 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has active ingredient	Almotriptan malate	false	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has specific active ingredient	Almotriptan hydrogen malate	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Almotriptan	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Has basis of strength substance	Almotriptan	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Almotriptan 12.5mg tablets (DE Pharmaceuticals) 3 tablet	Has AMP	True	Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals) 6 tablet	Has AMP	True	Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Inferred relationship	Existential restriction modifier
Almotriptan 12.5mg tablets (DE Pharmaceuticals) 9 tablet	Has AMP	True	Almotriptan 12.5mg tablets (DE Pharmaceuticals)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93689101000001115	Almotriptan 12.5mg tablets (DE Pharmaceuticals) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93689201000001110	Almotriptan 12.5mg tablets (DE Pharmaceuticals)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module